Clinical Research Directory

Inclusion Criteria: * Subjects voluntarily participated in the trial and signed the informed consent form; * Aged ≥ 18 years and \< 80 years, regardless of gender; * Stable vital signs; * Patients with gastric adenocarcinoma confirmed by gastroscopic biopsy; * Tumors judged as unresectable by attending physicians; * Receiving anti-PD-1 therapy combined with chemotherapy as first-line treatment; * No history of allergic diseases and non-allergic constitution; * No history of drug abuse; * Non-pregnant and non-lactating females (applicable to male subjects as well); * No participation in any drug clinical trial (including investigational drugs of this trial) within 3 months prior to enrollment. Exclusion Criteria: * Failure to meet the inclusion criteria, or individuals deemed inappropriate for trial participation by investigators; * Concurrent primary malignant tumors at other sites; * Poor general condition, severe infection, respiratory insufficiency, or other conditions leading to inability to cooperate with the trial; * Patients with mental disorders, consciousness disturbance, or poor treatment compliance; * Suspected or confirmed history of drug abuse; * Immunodeficiency, or long-term use of immunosuppressants and glucocorticoids; * Pregnant or lactating women; * Sponsors, investigators directly involved in this trial, and their immediate family members; * Individuals unsuitable for enrollment for any reason as judged by the investigator.